In summary, circABCC4 mediated the activation of glycolysis in CAFs by promoting PKM2 nuclear translocation, resulting in reducing DNA damage in tumor cells and consequently leading to oxaliplatin resistance. The gene discussed is PKM; the disease is neoplasm.